7,227 patients studied to map h. pylori drug resistance in nanjing
NCT ID NCT07455448
First seen Mar 13, 2026 · Last updated May 12, 2026 · Updated 4 times
Summary
This study looked at 7,227 patients in Nanjing to understand how resistant the H. pylori bacteria is to common antibiotics. Researchers tested the bacteria's resistance patterns and genetic mutations. The goal is to help doctors choose the right antibiotics for each patient, making treatment more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
Conditions
Explore the condition pages connected to this study.